SH MEDLAB: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SH MEDLAB
Largest movements
- Cash +€222,782
up €222,782 (+839.2%), from €26,546 to €249,328
mainly Net result for the year (+€166,215) and Tax, wage and social debts (+€55,521)
- Reserves +€166,215
up €166,215 (+909.4%), from €18,278 to €184,493
- Tax, wage and social debts +€55,521
up €55,521 (+784.5%), from €7,077 to €62,598
- Gross operating margin +€214,195
up €214,195 (+811.2%), from €26,404 to €240,599
- Taxes +€65,945
up €65,945 (+931.8%), from €7,077 to €73,021
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €27,922 | €249,728 | +€221,806 | +794.4% |
| Formation expenses | 20 | €796 | - | -€796 | |
| Fixed assets | 21/28 | - | €400 | +€400 | |
| Tangible fixed assets | 22/27 | - | €400 | +€400 | |
| Furniture and vehicles | 24 | - | €400 | +€400 | |
| Current assets | 29/58 | €27,126 | €249,328 | +€222,202 | +819.1% |
| Amounts receivable within one year | 40/41 | €580 | - | -€580 | |
| Other amounts receivable | 41 | €580 | - | -€580 | |
| Cash at bank and in hand | 54/58 | €26,546 | €249,328 | +€222,782 | +839.2% |
| Total equity and liabilities | 10/49 | €27,922 | €249,728 | +€221,806 | +794.4% |
| Equity | 10/15 | €20,278 | €186,493 | +€166,215 | +819.7% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €18,278 | €184,493 | +€166,215 | +909.4% |
| Distributable reserves | 133 | €18,278 | €184,493 | +€166,215 | +909.4% |
| Amounts payable | 17/49 | €7,644 | €63,235 | +€55,591 | +727.2% |
| Amounts payable within one year | 42/48 | €7,644 | €63,235 | +€55,591 | +727.2% |
| Trade debts | 44 | €567 | €203 | -€365 | -64.3% |
| Suppliers | 440/4 | €567 | €203 | -€365 | -64.3% |
| Taxes, remuneration and social security | 45 | €7,077 | €62,598 | +€55,521 | +784.5% |
| Taxes | 450/3 | €7,077 | €62,598 | +€55,521 | +784.5% |
| Other amounts payable | 47/48 | - | €434 | +€434 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €584 | €944 | +€359 | +61.5% |
| Other operating charges | 640/8 | €450 | €316 | -€134 | -29.7% |
| Gross operating margin | 9900 | €26,404 | €240,599 | +€214,195 | +811.2% |
| Operating profit (loss) | 9901 | €25,370 | €239,340 | +€213,970 | +843.4% |
| Financial income | 75/76B | €1 | €4 | +€3 | +652.0% |
| Recurring financial income | 75 | €1 | €4 | +€3 | +652.0% |
| Financial charges | 65/66B | €16 | €107 | +€91 | +580.2% |
| Recurring financial charges | 65 | €16 | €107 | +€91 | +580.2% |
| Profit (loss) for the period before taxes | 9903 | €25,355 | €239,236 | +€213,882 | +843.6% |
| Income taxes | 67/77 | €7,077 | €73,021 | +€65,945 | +931.8% |
| Profit (loss) for the period | 9904 | €18,278 | €166,215 | +€147,937 | +809.4% |
| Profit (loss) for the period to be appropriated | 9905 | €18,278 | €166,215 | +€147,937 | +809.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.